Supplement to: Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
- Salloway, S
- Sperling, R
- Fox, N C
New England Journal of Medicine 370(4), January 23, 2014.

Copyright © 2014 Massachusetts Medical Society. All rights reserved.